Yes—34 reported cases linked Statins to sudden pancreas swelling, starting anywhere from 8 hours to 10 years after use began. A 2026 review gathered published reports found through May 31, 2025. The people described were ages 36 to 86, with a middle age of 59. Reports involved six types of Statins, medicines used to lower cholesterol. Cases occurred at both low and high doses. The middle time until illness began was 3.5 months. Blood tests showed raised Lipase, an enzyme that helps break down fats. Its middle value was 1,730.5 U/L, with values from 82 to 5,579 U/L. Here, “middle” means half the values were higher and half lower. Amylase, another digestive enzyme, had a middle value of 742 U/L. Belly pain affected 67.6% of people, and 38.2% had vomiting. Nausea affected 29.4%. Scans could also show swelling in the pancreas. After the medicines were stopped and treatment was given, 94.1% recovered. The review reported that 5.8% died. These reports flag a possible link, not how common it is. There was no comparison group or count of all people taking these medicines. The review cannot tell us any one person's risk. It also cannot show that dose or time on treatment makes no difference. For BioSocial members tracking Lipase, the useful takeaway is context. A dated record can place blood results beside medicine start dates and symptoms. Comparing those timelines with the community may make shared results easier to understand. A single number cannot establish what caused a change. What have your Lipase results looked like over time, alongside medicine changes or symptoms?